Very encouraging, there must have been some substantial over- subscriptions offsetting the unders & nils. Good result given what us shareholders have been through in the past couple of years. Well played.
I retreived from somewhere in the murky depths of my brain some Year 10 algebra from 40+ years ago & estimated the placement STM would require to maintain their 23% holding. Assuming the Chinese govt approves the transaction. . .
.
.
Column 1 Column 2 0 Current shares on issue 683,439,799 1 Rights issue 85,429,350 2 New shares on issue 768,864,149 3 Est. Shandong placement 25,517,863 4 Est. shares on issue 794,382,012 5 ------------------------------ -------------------- 6 Shandong current 157,190,000 7 Est. Shandong placement 25,517,863 8 Est. Shandong holding 182,707,863 9 Est. proceeds @7c $1,786,250
The cynic in me says that until this occurs STM would have no interest in an imminent rise in the SP. Another consideration is that in mid March STM can acquire a further 3% under creeping acquisition provisions.
Bring on the DFS.
- Forums
- ASX - By Stock
- TON
- 72% uptake
72% uptake, page-12
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TON (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
-0.001(10.0%) |
Mkt cap ! $14.11M |
Open | High | Low | Value | Volume |
0.9¢ | 1.0¢ | 0.9¢ | $28.26K | 2.949M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 1300888 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 733883 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 1300888 | 0.009 |
11 | 2603061 | 0.008 |
5 | 2049619 | 0.007 |
5 | 931975 | 0.006 |
2 | 899995 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 733883 | 3 |
0.011 | 1900813 | 7 |
0.012 | 1245909 | 3 |
0.013 | 500000 | 1 |
0.014 | 299399 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
TON (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online